Navigation Links
Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
Date:12/12/2007

Company's ability to build and maintain successful partnerships, patient recruitment expertise and its global reach cited as reasons for selection

CINCINNATI, Dec. 12 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization (CRO), today announced it was named "Best CRO" at the Scrip Awards held Dec. 4 in London. Kendle was selected from among leading global CROs by a distinguished panel of pharmaceutical industry executives. The annual awards competition, organized by Scrip World Pharmaceutical News, a leading provider of news and analysis for the global biopharmaceutical industry, is designed to recognize new standards of excellence and celebrate achievements that reflect cutting-edge science and the intellectually exciting and socially rewarding nature of the industry. This is the second year in a row Kendle has received the "Best CRO Award."

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

"Kendle is honored to be recognized once again by the Scrip expert panel as 'Best CRO'," noted Candace Kendle, PharmD, Chairman and Chief Executive Officer. "In a service business it's all about people, and at Kendle our associates offer exceptional qualities that make a real difference to our customers."

According to Scrip World Pharmaceutical News, "The judges felt that among Kendle's strengths are its ability to build and maintain successful partnerships, its global reach, patient recruitment expertise, its skills in core therapeutic areas as well as niche areas and its extensive pregnancy registry."

Selection criteria for the award included performance across multiple categories, including range of capabilities, exceeding sponsor expectations, ability to build solid long-term working relationships within biopharmaceutical companies, quality of data management and innovative strategies for regulatory guidance. In their deliberations, the judges looked at the range of services provided by the entrants, measures they have implemented to improve their performance or offer new services and the quality of their relationships with their customers.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
2. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
3. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
4. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
7. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
8. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
11. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... (PRWEB) , ... May 05, 2016 , ... ... is proud to support the National Stroke Association during National Stroke Awareness Month ... association’s Facebook and Twitter pages throughout the month. CereScan will donate $1 ...
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... PBI-Gordon Corporation ... and Agricultural Sales. , Doug began his career at PBI-Gordon in February 1988, ... in a wide variety of roles, ranging from customer service to national product manager, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Morf Media ... compliance training platform on mobile devices, today released a new interactive Food ... Medical Devices. The course is essential for owners or operators of places of ...
Breaking Biology Technology:
(Date:3/14/2016)... MELBOURNE, Florida , March 14, 2016 ... on the growing mobile commerce market, announces the airing of ... York channels starting the week of March 21 st . ... and CNBC, including its popular Squawk on the Street show. ... company focused on the growing mobile commerce market, announces the ...
(Date:3/11/2016)... 11, 2016 http://www.apimages.com ) - --> ... is available at AP Images ( http://www.apimages.com ) - ... used to produce the new refugee identity cards. DERMALOG will be ... CeBIT in Hanover next week.   --> ... be used to produce the new refugee identity cards. DERMALOG will ...
(Date:3/10/2016)... --> --> ... and Access Management Market by Component (Provisioning, Directory Services, ... Organization Size, by Deployment, by Vertical, and by Region ... market is estimated to grow from USD 7.20 Billion ... a Compound Annual Growth Rate (CAGR) of 12.2% during ...
Breaking Biology News(10 mins):